Search Drug Information, Interactions, Images, Dosage & Side Effects

Durvalumab + tremelimumab + chemo: A new first-line SoC for mNSCLC? 26 Oct 2021

The combination of durvalumab, tremelimumab, and chemotherapy in the first-line setting improved progression-free survival (PFS) and overall survival (OS) in patients with metastatic non-small-cell lung cancer (mNSCLC), according to results of the phase III POSEIDON trial.

Atrophic gastritis, PPI use amplify EC risk in immunocompetent patients

26 Oct 2021

Baricitinib prevents death in critically ill COVID-19 patients

26 Oct 2021

Everolimus helps fight recurrent thymic neuroendocrine neoplasia

26 Oct 2021

OPUS treatment proven effective in first-episode psychosis

26 Oct 2021

Therapeutic heparin may reduce death, bleeding risks in moderate COVID-19

26 Oct 2021

Wearable robot helps with post-TKA rehab

26 Oct 2021

Minimally invasive surgery feasible for nonendometroid endometrial cancers

26 Oct 2021

Mendelian analysis links coffee drinking to lower kidney stone risk

26 Oct 2021

Total diet replacement helps shed pounds among individuals with obesity

26 Oct 2021

Interdisciplinary treatment suppresses chronic pain-related absences from work

25 Oct 2021

Kids hard-hit by Delta; which ART performs best? 24 Oct 2021;
That COVID-19 mostly spared children might be changing. The Delta variant has taken a severe, unthinkable toll on kids – at least in Arkansas, US, reports an expert at IDWeek 2021.

Rapid COVID-19 testing: Is it as good in kids?

Roshini Claire Anthony, 20 Oct 2021

A new paradigm for T2DM care in the era of SGLT-2i

01 Oct 2021

Early initiation of Enstilar® in managing plaque psoriasis provides better patient outcomes

01 Oct 2021

Lixiana

Contents : Edoxaban tosilate

Indications/Uses : Prevention of stroke & systemic embolism in adult patients w/ nonvalvular atrial fibrillation (NVAF) w/ ≥1 risk factors eg, CHF, HTN, age ≥75 yr, DM, prior stroke or transient ischaemic attack. Treatment of deep vein thrombosis (DVT) & pulmonary embolism (PE) in adults. Prevention of recurrent DVT & PE in adults.

Relizema/DermaRel

Contents : Relizema cream Aqua, hydrogenated polydecene, ethylhexyl palmitate, dimethicone, glycerin, glyceryl stearate, PEG-100 stearate, cetearyl alcohol, Mg stearate, Ricinus communis seed oil, phenoxyethanol, ascorbyl palmitate, disodium EDTA, ethylhexylglycerin, furfuryl palmitate, ethyl linolenate, tocopheryl acetate, Na hyaluronate, ethyl oleate, ethyl linoleate, propyl gallate, tocopherol, ethyl palmitate, ethyl stearate. DermaRel Ultra Hydrating Lotion Aqua, Butyrospermum parkii butter, hydrogenated polyisobutene, ethylhexyl stearate, glycerin, cetearyl alcohol, methylpropanediol, cetearyl glucoside, caprylyl glycol, K cetyl phosphate, xanthan gum, phenylpropanol, Linum usitatissimum seed oil, Prunus amygdalus dulcis oil, Olea europaea fruit oil, disodium EDTA, C12-15 alkyl benzoate, Borago officinalis seed oil, tribehenin, Na lauroyl lactylate, Na hydroxide, tocopherol, ceramide NG, PEG-10 phytosterol, ceramide NP, phenoxyethanol, lactic acid, ceramide AP, phytosphingosine, cholesterol, carbomer, ethylhexylglycerin, palmitoyl hexapeptide-12, ceramide EOP. DermaRel Lipid-Replenishing Cleanser Aqua, methylpropanediol, disodium cocoamphodiacetate, cocamidopropyl betaine, PEG-7 glyceryl cocoate, carbomer, caprylyl glycol, NaCl, acrylates/C10-30 alkyl acrylate crosspolymer, phenethyl alcohol, Na hydroxide, phenylpropanol, niacinamide, disodium EDTA, glycine, proline, ethylhexylglycerin, Na benzoate, arginine, Na lauroyl lactylate, pentylene glycol, glycerin, urea, citric acid, fructose, ceramide NP, phenoxyethanol, Na lactate, trehalose, allantoin, phytosphingosine, ceramide AP, maltose, Na PCA, cholesterol, xanthan gum, Na hyaluronate, glucose, ceramide EOP. DermaRel Spray & Go Aqua, Zn oxide, cetearyl isononanoate, glycerin, C12-13 alkyl lactate, kaolin, talc, taurine, glyceryl stearate, ethylhexylglycerin, Zn gluconate, Mg Al silicate, ceteareth-20, Chondrus crispus powd, ceteareth-12, cetearyl alcohol, cetyl palmitate, panthenol, Butyrospermum parkii butter, hexamidine diisethionate, citric acid

Indications/Uses : Relizema cream Symptomatic treatment of dermatitis & erythema. Itching & flushing associated w/ dermatitis including atopic & contact dermatitis. DermaRel Ultra Hydrating Lotion Hydrates, moisturises & protects sensitive & dry skin of adults & childn. DermaRel Lipid-Replenishing Cleanser Cleanses, hydrates, moisturizes & protects dry & sensitive face & body skin of adults & childn. DermaRel Spray & Go Protects & soothes delicate & sensitive skin of babies & elderly.

Cresemba

Contents : Isavuconazole

Indications/Uses : Invasive aspergillosis; mucormycosis in patients for whom amphotericin B is inappropriate.

Prevymis

Contents : Letermovir

Indications/Uses : Prophylaxis of cytomegalovirus (CMV) infection & disease in adult CMV-seropositive recipients [R+] of an allogeneic haematopoietic stem cell transplant (HSCT).

Zinforo

Contents : Ceftaroline fosamil

Indications/Uses : Community-acquired pneumonia (CAP), complicated skin & soft tissue infections (cSSTI) in patients from 2 mth.

Cabometyx

Contents : Cabozantinib

Indications/Uses : Advanced renal cell carcinoma in treatment-naive adults w/ intermediate or poor risk; adults following prior vascular endothelial growth factor-targeted therapy. Monotherapy for hepatocellular carcinoma in adults who have previously been treated w/ sorafenib.

Viacoram

Contents : Perindopril arginine 3.5 mg, amlodipine 2.5 mg

Indications/Uses : Initial therapy in patients w/ mild to moderate essential HTN for whom combination therapy is appropriate.

Cavsamir

Contents : Sevelamer carbonate

Indications/Uses : Control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis, or chronic kidney disease (CKD) not on dialysis w/ serum P ≥1.78 mmol/L.